References
- The war in South Africa. BMJ [Internet]. Br Med J Publishing Group. 1900 Jul 7 [cited 2018 Apr 18];2(2062):49–53. DOI:10.1136/bmj.2.2062.49
- Mogasale V, Maskery B, Ochiai RL, et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Heal [Internet]. 2014 Oct [cited 2016 Jun 28];2(10):e570–e80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25304633
- Wong VK, Baker S, Pickard DJ, et al. Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events. Nat Genet [Internet]. 2015 May 11 [cited 2016 Dec 7];47(6):632–639. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25961941
- Feasey NA, Gaskell K, Wong V, et al. Rapid emergence of multidrug resistant, H58-lineage Salmonella typhi in Blantyre, Malawi. PLoS Negl Trop Dis. 2015;9(4).
- Klemm EJ, Shakoor S, Page AJ, et al. Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio [Internet]. Am Soc Microbiol. 2018 Feb 20 [cited 2018 Apr 18];9(1):e00105–e18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29463654
- Burki T. Typhoid conjugate vaccine gets WHO prequalification. Lancet Infect Dis [Internet]. Elsevier. 2018 Mar 1 [cited 2018 Mar 7];18(3):258. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29485093
- Jin C, Gibani MM, Moore M, et al. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. Lancet (London, England) [Internet]. Elsevier; 2017 Sep 28 [cited 2017 Oct 11]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/28965718
- Marks F, von Kalckreuth V, Aaby P, et al. Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study. Lancet Glob Heal [Internet]. 2017 Mar [cited 2017 Feb 27];5(3):e310–e23. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2214109X17300220
- Pitzer VE, Feasey NA, Msefula C, et al. Mathematical modeling to assess the drivers of the recent emergence of typhoid fever in Blantyre, Malawi. Clin Infect Dis [Internet]. 2015 Nov 1 [cited 2016 Nov 18];61(suppl 4):S251–S8. Available from: http://cid.oxfordjournals.org/lookup/doi/10.1093/cid/civ710
- Lutterloh E, Likaka A, Sejvar J, et al. Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis. 2012 Apr;54(8):1100–1106. United States.
- Neil KP, Sodha SV, Lukwago L, et al. A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008–2009. Clin Infect Dis. 2012 Apr;54(8):1091–1099. United States.
- Kabwama SN, Bulage L, Nsubuga F, et al. A large and persistent outbreak of typhoid fever caused by consuming contaminated water and street-vended beverages: Kampala, Uganda, January–June 2015. BMC Public Health [Internet]. BioMed Central. 2017 Jan 5 [cited 2017 Aug 3];17(1):23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28056940
- Wong VK, Holt KE, Okoro C, et al. Molecular surveillance identifies multiple transmissions of typhoid in West Africa. Ryan ET, editor. PLoS Negl Trop Dis [Internet]. 2016 Sep 22 [cited 2016 Nov 23];10(9):e0004781. Public Library of Science. Available from: http://dx.plos.org/10.1371/journal.pntd.0004781
- WHO | SAGE meeting of October 2017. WHO [Internet]. World Health Organization. 2017 [cited 2018 Jan 21]; Available from: http://www.who.int/immunization/sage/meetings/2017/october/presentations_background_docs/en/
- Wahdan MH, Serie C, Germanier R, et al. A controlled field trial of liver oral typhoid vaccine Ty21a. Bull World Health Organ. 1980;58(3):469–474. Switzerland.
- Klugman KP, Gilbertson IT, Koornhof HJ, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet. 1987 Nov;2(8569):1165–1169.
- WHO |. Weekly Epidemiological Record; 8 February 2008;83(6):49–60. WHO 2012.
- Kossaczka Z, Lin FY, Ho VA, et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun. United States. 1999 Nov;67(11):5806–5810.
- Mohan VK, Varanasi V, Singh A, et al. Safety and immunogenicity of a Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study. Clin Infect Dis [Internet]. 2015 Aug 1 [cited 2016 Dec 8];61(3):393–402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25870324
- Antillón M, Bilcke J, Paltiel AD, et al. Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings. Vaccine [Internet]. Elsevier; 2017 Jun 14 [cited 2017 Oct 11];35(27):3506–3514. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28527687
- Park SE Severe typhoid fever surveillance in Africa (SETA) program: first data from the six African sites. [cited 2018 May 9]; Available from: http://www.coalitionagainsttyphoid.org/wp-content/uploads/2016/07/22-SETA-The-First-Data-from-the-Six-African-Sites.pdf
- Darton TC, Meiring JE, Tonks S, et al. The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys. BMJ Open [Internet]. 2017 Jun 2 [cited 2017 Jul 26];7(6):e016283. Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2017-016283
- Gavi TVA Millions of children set to be protected against typhoid fever Gavi, the vaccine alliance [internet]. [cited 2018 Apr 19]. Available from: https://www.gavi.org/library/news/press-releases/2017/millions-of-children-set-to-be-protected-against-typhoid-fever/
- Carole Tevi-Benissan M, Moturi E, Anya B-PM, et al. Contribution of polio eradication initiative to effective new vaccine introduction in Africa, 2010–2015. Vaccine [Internet]. 2016 Oct 10 [cited 2018 Apr 19];34(43):5193–5198. Elsevier. Available from: https://www.sciencedirect.com/science/article/pii/S0264410X16303899?via%3Dihub
- Bar-Zeev N, Kapanda L, Tate JE, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect Dis [Internet]. 2015 Apr 1 [cited 2018 Apr 20];15(4):422–428. Elsevier. Available from: https://www.sciencedirect.com/science/article/pii/S1473309914710606?via%3Dihub
- McCollum ED, Nambiar B, Deula R, et al. Impact of the 13-valent pneumococcal conjugate vaccine on clinical and hypoxemic childhood pneumonia over three years in central Malawi: an observational study. Borrow R, editor. PLoS One [Internet]. 2017 Jan 4 [cited 2018 Apr 20];12(1):e0168209. Public Library of Science. DOI:10.1371/journal.pone.0168209